TWO-YEAR DURABILITY/SAFETY OF ONETIME LONVOGURAN ZICLUMERAN (LONVO-Z, NTLA-2002) 50MG IN PATIENTS WITH HEREDITARY ANGIOEDEMA

Authors
Category Primary study
JournalAnnals of allergy, asthma and immunology
Year 2025
This article has no abstract
Epistemonikos ID: fb72ddd35114924f8c33df531afa3f2db700dd97
First added on: Feb 28, 2026